• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Iridex shows its latest infrared photocoagulator

Article

Iridex presented its IRIS Medical IQ 810, a state-of-the-art infrared photocoagulator, to attendees at the European Society of Cataract and Refractive Surgeons meeting.

Paris—Iridex presented its IRIS Medical IQ 810, a state-of-the-art infrared photocoagulator, to attendees at the European Society of Cataract and Refractive Surgeons meeting.

Designed to perform traditional and the company's Minimum Intensity Photocoagulation (MIP) procedures, the infrared diode laser features SmartWave interactive software for intuitive set up and operation, customized laser output, and settings and integrated system diagnostics. SmartWave also enables quick access to the unit's CW-Pulse (continuous-wave), MicroPulse, and LongPulse operation modes.

The IQ 810 offers graphic user interface, permitting treatment settings to be reviewed, programmed, and monitored quickly and easily. The display features a wide angle of view and sharp contrast that provides clear visibility under a range of light conditions. Lightweight and portable, the unit is compatible with a variety of delivery devices made by Iridex.

The IQ 810 is not for sale in the United States.

Related Videos
Paul Badawi, co-founder and CEO of Sight Sciences, chats with Neda Shamie, MD, about what drives him
© 2024 MJH Life Sciences

All rights reserved.